Yeruusaalem, 11 Noofambar, 2026 (TPS-IL) — Shirkadda dawooyinka bayoolajiga ee Israa‘iili LifeBiotic ayaa tijaabo caafimaad oo Wajiga 2-aad oo kala soocan ka bilowday Xarunta Daryeelka Caafimaadka ee Rambam ee Xayfaa si loo qiimeeyo bal in musharraxa dawo dhireedku uu gacan ka geysan karo ka hortagga soo noqoshada kansarka kaadiheysta. Tijaabadan oo ay ku lug leeyihiin 60 bukaan ayaa lagu qiimeyn doonaa badbaadada iyo waxtarka LCS103, oo ah dawo afka laga qaato oo isku daraysa maaddooyin dhir laga keenay, iyada oo la barbar wado daawaynta caadiga ah.
Daraasaddan ayaa daba socota kiisas taxane ah oo la daabacay 2024 oo ay ku lug lahaayeen 20 bukaan, kuwaas oo lagu ogaaday in saamiga dadka ay soo noqoshadu ku dhacday uu ka soo dhacay 55% kahor daawaynta oo uu gaaray 15% kadib markii la bilaabay LCS103. Cilmi-baarayaashu waxay hadda natiijooyinkaas horudhaca ah ku tijaabin doonaan tijaabo la kantaroolo, iyagoo baaraya soo noqoshada kansarka, badbaadada iyo tayada nolosha bukaannada.
